Breaking News

Monday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
NVS Novartis $77.08 -0.07 (-0.09%) , LMNX Luminex $27.19 0.8 (3.03%) … 07:30 05/21/18 05/21 07:30 05/21/18 07:30 Conference/Events	UBS to hold a conference » Global Healthcare… Global Healthcare Conference will be held in New York on May 21-23 with webcasted company presentations to begin on May 21 at 8 am; not all company presentations may be webcasted. Webcast Link NVS Novartis $77.08 -0.07 (-0.09%) LMNX Luminex $27.19 0.8 (3.03%) MTEM Molecular Templates $7.30 -0.045 (-0.61%) AMRX Amneal Pharmaceuticals $17.14 0.36 (2.15%) DCPH Deciphera $25.29 -0.5 (-1.94%) HSIC Henry Schein $71.93 -0.35 (-0.48%) MNOV MediciNova $9.88 -0.54 (-5.18%) ANGO AngioDynamics $20.08 0.29 (1.47%) SURF Surface Oncology $14.19 0.19 (1.36%) BIIB Biogen $280.35 -0.34 (-0.12%) OBLN Obalon Therapeutics $2.63 0.03 (1.15%) HIIQ Health Insurance Innovations $29.10 0.6 (2.11%) JNJ Johnson & Johnson $124.27 0.45 (0.36%) FLDM Fluidigm $5.75 -0.04 (-0.69%) MRNS Marinus Pharmaceuticals $4.64 0.08 (1.75%) ADUS Addus HomeCare $52.95 -0.15 (-0.28%) SKHCY Sonic Healthcare $0.00 (0.00%) ENDP Endo $6.11 -0.09 (-1.45%) ONCE Spark Therapeutics $76.72 0.77 (1.01%) MOR MorphoSys $26.33 -0.29 (-1.09%) RTIX RTI Surgical $4.65 0.1 (2.20%) IART Integra LifeSciences $64.62 0.54 (0.84%) NVTA Invitae $6.80 0.26 (3.98%) BTAI BioXcel Therapeutics $10.44 (0.00%) WST West Pharmaceutical $89.25 0.845 (0.96%) TTPH Tetraphase $3.67 0.02 (0.55%) ESPR Esperion $42.13 -0.71 (-1.66%) ALKS Alkermes $46.27 0.25 (0.54%) FVE Five Star Senior Living $1.15 (0.00%) IOVA Iovance Biotherapeutics $17.00 0.65 (3.98%) SGRY Surgery Partners $18.80 -0.6 (-3.09%) PKI PerkinElmer $75.56 1.14 (1.53%) ICPT Intercept $72.48 1.35 (1.90%) ATNX Athenex $16.97 (0.00%) MMSI Merit Medical $53.70 1.05 (1.99%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 May 22 May 29 May 29 May 30 May 30 May 31 May 01 Jun 05 Jun 05 Jun 12 Jun 19 Jun 25 Jun 26 Jun 28 Aug 10 Sep 31 Jan

Over a week ago
ATNX Athenex $17.52 0.7 (4.16%) 07:10 05/14/18 05/14 07:10 05/14/18 07:10 Earnings	Breaking Earnings news story on Athenex » Athenex backs FY18… Athenex backs FY18 revenue guidance of $100M-$125M, consensus $112.54M 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 May 21 May
ATNX Athenex $17.52 0.7 (4.16%) 07:09 05/14/18 05/14 07:09 05/14/18 07:09 Earnings	Breaking Earnings news story on Athenex » Athenex reports Q1… Athenex reports Q1 revenue $37.84M, consensus $35.14M 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 May 21 May

Over a month ago
ATNX Athenex $17.20 -0.08 (-0.46%) 08:12 04/19/18 04/19 08:12 04/19/18 08:12 Hot Stocks	Athenex receives FDA Orphan Drug Designation for Oraxol » Athenex announced that it… Athenex announced that it has received Orphan Drug Designation from the U.S. FDA for Oraxol for the treatment of angiosarcoma. Oraxol, an innovative development in the treatment of cancer, is a novel oral formulation of paclitaxel, a very effective and commonly used chemotherapy treatment for many cancers, combined with HM30181A. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	08 May 21 May
ATNX Athenex $17.15 (0.00%) 10:05 04/17/18 04/17 10:05 04/17/18 10:05 Hot Stocks	Athenex's Oraxol granted orphan status for treatment of angiosarcoma » The FDA granted… The FDA granted Athenex's Oraxol orphan status for the treatment of angiosarcoma.Reference Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	08 May 21 May

ATNX Athenex $16.19 -0.19 (-1.16%) 07:05 03/26/18 03/26 07:05 03/26/18 07:05 Earnings	Breaking Earnings news story on Athenex » Athenex sees FY18 revenue… Athenex sees FY18 revenue $100M-$125M, consensus $68.56M 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Mar
ATNX Athenex $16.19 -0.19 (-1.16%) 07:04 03/26/18 03/26 07:04 03/26/18 07:04 Earnings	Breaking Earnings news story on Athenex » Athenex reports Q4… Athenex reports Q4 revenue $14.9M, consensus $20.59M 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Mar
ATNX Athenex $15.98 -0.14 (-0.87%) 08:09 03/06/18 03/06 08:09 03/06/18 08:09 Initiation	Athenex initiated at Needham » Athenex initiated with a… Athenex initiated with a Buy at Needham. Needham analyst Chad Messer initiated Athenex with a Buy rating and a price target of $30, saying the company is evolving into a global pharma entity with both API and commercial product manufacturing development. Messer sees its Orascovery platform as a key value driver, potentially "enabling oral delivery of traditionally I.V. forms of chemotherapy" which is not only more convenient and cost effective but also reduces the high peak and low trough drug concentrations inherent in I.V. delivery. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Mar

Over a quarter ago
KPTI Karyopharm $14.80 0.21 (1.44%) , SGEN Seattle Genetics $54.11 -0.05 (-0.09%) … 04:55 02/22/18 02/22 04:55 02/22/18 04:55 Conference/Events	RBC Capital to hold a conference » Global Healthcare… Global Healthcare Conference will be held in New York on February 21-22. KPTI Karyopharm $14.80 0.21 (1.44%) SGEN Seattle Genetics $54.11 -0.05 (-0.09%) DBVT DBV Technologies $24.51 -0.52 (-2.08%) PGNX Progenics $5.84 -0.15 (-2.50%) CERN Cerner $63.37 0.37 (0.59%) ICPT Intercept $59.13 -1.65 (-2.71%) ATNX Athenex $15.99 -0.01 (-0.06%) ACRX AcelRx $1.88 (0.00%) CAH Cardinal Health $68.81 -0.03 (-0.04%) CHE Chemed $256.56 0.19 (0.07%) GILD Gilead $80.69 -0.25 (-0.31%) AVEO Aveo Oncology $2.94 0.03 (1.03%) HCA HCA Healthcare $100.35 -0.65 (-0.64%) IOVA Iovance Biotherapeutics $17.75 0.6 (3.50%) KTWO K2M Group $19.09 -0.01 (-0.05%) DEPO Depomed $7.46 0.07 (0.95%) EDGE Edge Therapeutics $14.66 0.88 (6.39%) RDNT RadNet $10.15 0.15 (1.50%) ARNA Arena Pharmaceuticals $41.19 0.67 (1.65%) ANCR Ancor Communications $0.00 (0.00%) IMGN ImmunoGen $11.68 0.43 (3.82%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb 22 Feb 26 Feb 27 Feb 28 Feb 28 Feb 05 Mar 11 Mar 12 Mar 14 Mar 04 Apr 30 Apr 01 May
KPTI Karyopharm $14.59 -0.39 (-2.60%) , SGEN Seattle Genetics $54.16 -0.32 (-0.59%) … 07:18 02/21/18 02/21 07:18 02/21/18 07:18 Conference/Events	RBC Capital to hold a conference » Global Healthcare… Global Healthcare Conference will be held in New York on February 21-22. KPTI Karyopharm $14.59 -0.39 (-2.60%) SGEN Seattle Genetics $54.16 -0.32 (-0.59%) DBVT DBV Technologies $25.03 -0.83 (-3.21%) PGNX Progenics $5.99 0.02 (0.34%) CERN Cerner $63.00 -1.22 (-1.90%) ICPT Intercept $60.78 -0.38 (-0.62%) ATNX Athenex $16.00 -0.66 (-3.96%) ACRX AcelRx $1.88 -0.025 (-1.32%) CAH Cardinal Health $68.84 -0.5 (-0.72%) CHE Chemed $256.37 1.81 (0.71%) GILD Gilead $80.94 0.24 (0.30%) AVEO Aveo Oncology $2.91 -0.09 (-3.00%) HCA HCA Healthcare $101.00 (0.00%) IOVA Iovance Biotherapeutics $17.15 -0.8 (-4.46%) KTWO K2M Group $19.10 -0.23 (-1.19%) DEPO Depomed $7.39 -0.05 (-0.67%) EDGE Edge Therapeutics $13.78 -0.17 (-1.22%) RDNT RadNet $10.00 -0.05 (-0.50%) ARNA Arena Pharmaceuticals $40.52 -0.28 (-0.69%) ANCR Ancor Communications $0.00 (0.00%) IMGN ImmunoGen $11.25 -0.02 (-0.18%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 22 Feb 26 Feb 27 Feb 28 Feb 28 Feb 05 Mar 11 Mar 12 Mar 14 Mar 04 Apr 30 Apr 01 May

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial